At the very end of the hearing, the FDA’s Dr. Kweder (who wasn’t present for the bulk of the meeting) gave a brief monologue on the need to be vigilant about systemic safety, even though only a tiny proportion of Macugen leaks into general circulation. No one challenged those comments either.
Market Data 
Markets 
AI
